In our research program for investigating anti-dementia agents from natural plant resources, we screened extracts from 15 spice samples. Among the plant extracts tested, ethyl acetate extract prepared from rhizome of Zingiber zerumbet showed potent activity. Activity-guided purification led to determination of afzelin and its acetylated compound as the active principles. Afzelin showed moderate inhibitory activity against acetylcholinesterase and may also be expected to possess anti-butyrylcholinesterase activity. This is the first report to reveal the anti-cholinesterase activities of ethyl acetate extract of Z. zerumbet and afzelin. Furthermore, Z. zerumbet may be a potential therapeutic agent for the improvement of dementia, especially Alzheimer's disease.
In these circumstances, the importance of AD prevention has become important. The screening of various plant materials for the most suitable agents for long-term consumption was performed to obtain naturally originating inhibitors. Among them, turmerones showed relatively high inhibitory activities againt β-secretase at 39, 62 and 92 μM of IC 50 values for α-, β-and ar turmerones, respectively [1] . In addition, turmerones were shown to reach the brain in intact forms when administered orally [2] . These findings suggest that natural plant resources are a promising source for ADpreventive agents.
In our research to screen for effective agents for β-secretase, inhibitory activities against cholinesterases were also investigated in some samples [3] . Some extracts showed potent inhibitory activities suggesting that natural plant resources may be an ideal source. Cholinesterases, including acetyl and butyrylcholinesterases, play an important role in AD therapy. Administration of acetylcholinesterase inhibitors has been successful in curing AD, which suppresses the decrease of acetylcholine in the brain. In late stage AD, the level of butyrylcholine, which is the dominant neurotransmitter in the brain at that time, also decreases. This fact suggests that butyrylcholine is another important neurotransmitter to be considered. Thus, a butyrylcholinesterase inhibitor would be also be a promising candidate for AD therapy.
In this report, the screening of 15 natural plant extracts was performed for acetylcholinesterase inhibitors. Among the extracts tested, ethyl acetate extract from Zingiber zerumbet (ZZ) showed relatively potent inhibitory activity against acetylcholinesterase. This result prompted us to show the active principle and the inhibitory activities against butyrylcholinesterase.
The inhibitory activities of extracts from the spices used in curry in India were screened for β-secretase and acetylcholinesterase in previous paper [3] . In that report, turmeric (rhizome of Curcuma longa, Zingiberaceae), black pepper (fruit of Piper nigrum, Piperaceae) and curry leaf (leaf of Murraya koenigii, Rutaceae) extracts were active against both β-secretase and acetylcholinesterase. These results prompted us to expand the screening source to some Zingiberaceae, Piperaceae and Rutaceae plants used as spices along with some other common spices as follows: blue ginger (rhizome of Alpinia galanga, AG), wild turmeric (rhizome of Curcuma aromatica, CA), cinnamon (cortex of Cinnamomum zeylanicum, CI), saffron crocus (stigma of Crocus sativus, CS), white turmeric (rhizome of Curcuma zedoaria, CZ), cardamom (seed of Elettaria cardamomum, EC), aromatic ginger (rhizome of Kaempferia galanga, KG), betel (leaf of Piper betle, PB), long pepper (fruit of Piper longum, PL), clove (bud of Syzygium aromaticum, SA), sesame (seed of Sesamum indicum, SI), fenugreek (seed of Trigonella foenum-graecum, TF), Sichuan pepper (pericarp of Zanthoxylum bungeanum, ZB), ginger (rhizome of Zingiber officinale, ZO), and bitter ginger (rhizome of Zingiber zerumbet, ZZ). The extracts were screened in a β-secretase inhibition test and it was shown that the C. longa, EC, PL, CI, PB, CZ and KG extracts were active and their active principles were determined as various compounds differ in their skeleton, terpenoids, fatty acid derivatives phenylpropanoids [1] .
Using the same extract varieties in the extracting solvents, inhibitory activities against acetylcholinesterase were screened. Among the hexane extracts tested, PB showed the most potent activity at 74.3% of inhibition at 250 μg/mL (Figure 1 Zingiberaceae plants, ZO showed high potency at 49.4% on inhibition at 250 μg/mL. Among the ethyl acetate extracts tested, PB showed the highest activity at 88.2 and 96.8% of inhibition at 100 and 250 μg/mL, respectively ( Figure 2 ). ZZ showed relatively high activity at 63.8% of inhibition at 250 μg/mL. In the methanol extracts tested, CI showed the most potent activity at 81.3% of inhibition at 250 μg/mL ( Figure 3 ).
These data suggested that low polar extract of PB is a highly promising anti-AD agent. However, the anti-acetylcholinesterase activity of PB have already reported as described in previous reports [4] . The determination of the active principle would be very difficult due to the complexity of the extract as shown in the report and thus, the investigation was discontinued. Zingiberaceae plants were expected to show more potent activity according to the screening test on β-secretase inhibition. However, the inhibitory activities on acetylcholinesterase were moderate compared to the other plant samples tested in the experiment. Among them, the ethyl acetate extract of ZZ showed relatively potent activity. ZZ is a tropical plant indigenous to South Asian countries and known as wild ginger, bitter ginger or shampoo ginger [5] . The essential oil fraction contains 80~90% zerumbone which is recognized as a functional compound of the plant [6] . Interestingly, the ethyl acetate extract was free from zerumbone. In addition, zerumbone showed no inhibitory activity at 100 μM. These facts prompted us to investigate the active principle from the ethyl acetate extract of ZZ.
The extracts obtained from ZZ were tested for inhibitory activities against butyrylcholinesterase. Among the extracts tested, ethyl acetate extract showed the most potent activity at 55.8 and 69.6% of inhibition at 100 and 250 μg/mL, respectively (Figure 4) . The ethyl acetate extract of ZZ is a promising agent for AD therapy as it has inhibitory activities against both acetyl-and butyrylcholinesterases. To the best of our knowledge, this is the first report to show the cholinesterase activities of ZZ extracts. Activity-guided purification using acetyl-and butyrylcholinesterase led us to obtain fractions Fr. 5-1 and 5-2, which consisted of afzelin (kaempferol-3-O-α-L-rhamnoside) and its mono-and di-acetylated derivatives determined from NMR and MS data, respectcively ( Figure 5 ). The isolation of these compounds was impossible due to the lability of acetylated afzelin. The instability property of acetylated afzelin was demonstrated by preparing per-acetylated afzelin chemically and observing the deacetylation detected with HPLC. The inhibitory activity of afzelin only was determined since it was not possible to determine the inhibitory activities of acetylated afzelin in detail. For these reasons, only the cholinesterases activities of afzelin were evaluated. Afzelin showed 26.6 and 45.9% of inhibition at 50 and 100 μM, respectively. In addition, afzelin showed 18.4 and 36.8% of inhibition at same concentrations against butyrylcholinesterase. These data confirmed that afzelin is one of the active principles for the both cholinesterases contained in ZZ.
Afzelin is a flavonoid glycoside found in many plant materials. Murata et al. showed suppression activity on melanogenesis using B16 murine melanoma cell of afzelin [7] . This is the first report to demonstrate the anti-acetylcholinesterase activity of afzelin. This result suggests that afzelin may be a moderate therapeutic agent for AD. Further research on investigating other active principles has been performed in our laboratory and those results should be discussed elsewhere due to the moderate activity of afzelin.
Experimental
Reagents: Reagents used in this study were purchased from Wako Pure Chemicals (Osaka, Japan), Nacalai Tesque (Kyoto, Japan) or Sigma-Aldrich (St. Louis, MO), unless otherwise stated.
Preparation of extracts for screening: Blue ginger, wild turmeric, cinnamon, saffron crocus, white turmeric, cardamom, aromatic ginger, betel, long pepper, clove, sesame, fenugreek, Sichuan pepper, ginger and bitter ginger were provided by INABATA KORYO CO., LTD. The voucher specimens were deposited at the Faculty of Pharmacy at Kindai University.
Spice extracts were prepared according to the method previously reported and their yields were indicated in the report [1] . Spice samples were pulverized and soaked in 5 volumes/weight of nhexane for 1 h at 40˚C. The suspension was filtered and the residue was again soaked in the same volume of hexane for 30 min. at 40˚C. The suspension was filtered and the filtrates were combined and evaporated under reduced pressure to obtain the hexane extract. The residue of the hexane extract was dried at room temperature and extracted with ethyl acetate in the same manner as in the case of hexane to obtain the ethyl acetate extract. Methanol extraction was performed in the same manner to obtain the methanol extract. The yields of the extracts are shown in Table 1 . Cholinesterase inhibition test: Inhibitory activities against cholinesterase were evaluated according to the methods described previously [8] . Galanthamine hydrobromide and traisopropylpyrophosphoramide were used as positive control for acetylcholinesterase and butyrylcholinesterase, respectively. Statistical analysis: Statistical analysis was performed with oneway analysis of variance (ANOVA) followed by multiple comparison tests using a Bonferroni/Dunn algorithm. Statcel3 (OMS Publishing, Saitama, Japan) was used as a software. 
